Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyanka D Patel

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Human Vaccines & Immunotherapeutics|September 12, 2024
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian childrenNginache Nampota-Nkomba, Osward M Nyirenda, Victoria Mapemba, et al.
The Lancet. Global Health|August 12, 2022
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trialNginache Nampota-Nkomba, Osward M Nyirenda, Lameck Khonde, et al.
Lancet (London, England)|January 28, 2024
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian childrenPriyanka D Patel, Yuanyuan Liang, James E Meiring, et al.
Journal of Viral Hepatitis|January 25, 2022
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmissionAlexander J Stockdale, Benno Kreuels, Isaac T Shawa, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian ChildrenPriyanka D Patel, Pratiksha Patel, Yuanyuan Liang, et al.
Vaccine|May 16, 2026
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational dataNienke N Hagedoorn, Shruti Murthy, Christian S Marchello, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Human Vaccines & Immunotherapeutics|September 12, 2024
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian childrenNginache Nampota-Nkomba, Osward M Nyirenda, Victoria Mapemba, et al.
The Lancet. Global Health|August 12, 2022
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trialNginache Nampota-Nkomba, Osward M Nyirenda, Lameck Khonde, et al.
Lancet (London, England)|January 28, 2024
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian childrenPriyanka D Patel, Yuanyuan Liang, James E Meiring, et al.
Journal of Viral Hepatitis|January 25, 2022
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmissionAlexander J Stockdale, Benno Kreuels, Isaac T Shawa, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian ChildrenPriyanka D Patel, Pratiksha Patel, Yuanyuan Liang, et al.
Vaccine|May 16, 2026
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational dataNienke N Hagedoorn, Shruti Murthy, Christian S Marchello, et al.
Pageof 2